Inkef

Inkef is a prominent Amsterdam-based venture capital firm with a dedicated focus on early-stage investments across the European technology and healthcare sectors. Established in 2010, the firm operates as a subsidiary of ABP, one of the world's largest pension funds, providing it with a robust and patient capital base. This strategic backing allows Inkef to manage a substantial capital pool, exceeding €1 billion, which underpins its capacity for significant and sustained investment activity across its target markets. Their commitment extends to identifying and nurturing innovative companies poised for substantial growth within these critical industries.

The firm primarily targets Series A and Series B funding rounds, indicating a preference for companies that have demonstrated initial traction and are ready for scaling. Inkef's typical first cheque sizes range from €2 million to €20 million, which translates approximately to $2.16 million to $21.6 million, based on recent exchange rates. They frequently participate in larger syndicates, collaborating with other investors to provide comprehensive funding solutions. This collaborative approach not only de-risks investments but also brings diverse expertise to their portfolio companies, fostering a more robust support ecosystem.

Beyond capital provision, Inkef emphasizes a partnership-driven approach, actively supporting its portfolio companies through various stages of development. They leverage their extensive network and operational expertise to assist founders with strategic guidance, talent acquisition, and market expansion. Their long-term investment horizon, stemming from their institutional backing, enables them to commit to companies for extended periods, aligning with the often lengthy development cycles in deep tech and healthcare. This patient capital and hands-on support make Inkef a significant player in the European venture landscape, aiming to drive innovation and create lasting value.